Abstract | BACKGROUND: RESULTS: In a mouse model of cancer-induced pain, ephrin B1 gene expression in dorsal root ganglia (DRGs) and the phosphorylation of NR2B in the spinal cord were induced. Z-360 treatment inhibited both ephrin B1 gene expression and the phosphorylation of NR2B. In addition, IL-1β production increased in the cancer-inoculated hind paw of mice, but could be suppressed by treatment with Z-360. Moreover, we observed that the CCK1 receptor antagonist devazepide similarly suppressed up-regulation of ephrin B1 gene expression and IL-1β production, and that the intraperitoneal injection of sulfated CCK-8 induced the production of IL-1β in the cancer-inoculated region. CONCLUSIONS: We have identified a novel pain cascade, in which IL-1β production in cancer-inoculated regions induces ephrin B1 gene expression in DRGs and then ephrin B1 enhances the tyrosine phosphorylation of NR2B via Eph B receptor in the spinal cord. Notably, Z-360 relieves cancer-induced pain by preventing this pain cascade through the suppression of IL-1β production, likely via the blockade of CCK1 receptor. The pre-clinical results presented here support the analgesic action of Z-360 in pancreatic cancer patients with severe, opioid-resistant pain. Pre-clinical and clinical results have demonstrated that Z-360 combined with gemcitabine represents a promising pancreatic cancer therapy approach with characteristic analgesic effects in addition to the prolongation of survival.
|
Authors | Yuki Orikawa, Hiroki Kato, Koichi Seto, Nobuyoshi Kobayashi, Koji Yoshinaga, Hiroki Hamano, Yuko Hori, Tim Meyer, Mineo Takei |
Journal | Molecular pain
(Mol Pain)
Vol. 6
Pg. 72
(Oct 28 2010)
ISSN: 1744-8069 [Electronic] United States |
PMID | 20979661
(Publication Type: Journal Article)
|
Chemical References |
- 8-sulfocholecystokinin octapeptide
- Benzodiazepinones
- Ephrin-B1
- Interleukin-1beta
- NR2B NMDA receptor
- Receptors, N-Methyl-D-Aspartate
- Z-360
- Receptors, Eph Family
- Devazepide
- Sincalide
|
Topics |
- Animals
- Benzodiazepinones
(pharmacology, therapeutic use)
- Cell Line, Tumor
- Devazepide
(pharmacology)
- Disease Models, Animal
- Ephrin-B1
(genetics, metabolism)
- Extremities
- Ganglia, Spinal
(drug effects, metabolism, pathology)
- Gene Expression Regulation, Neoplastic
(drug effects)
- Injections
- Interleukin-1beta
(administration & dosage, biosynthesis, pharmacology)
- Mice
- Pain
(etiology, genetics, pathology)
- Pancreatic Neoplasms
(complications, drug therapy)
- Phosphorylation
(drug effects)
- Receptors, Eph Family
(genetics, metabolism)
- Receptors, N-Methyl-D-Aspartate
(metabolism)
- Sincalide
(analogs & derivatives, pharmacology)
- Up-Regulation
(drug effects)
|